Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation Using Induction Treatment of the Non-Hematopoetic Erythropoietin Analogue Cibinetide in a Mouse Model
Ming Yao(Karolinska University Hospital), Makiko Kumagai‐Braesch(Karolinska University Hospital), Anthony Cerami(Araim Pharmaceuticals (United States)), Michael Brines(Northwell Health), Kazuaki Tokodai(Karolinska University Hospital), Torbjörn Lundgren(Karolinska University Hospital), Sune Sun(Karolinska University Hospital), B.-G. Ericzon(Karolinska University Hospital), Masaaki Waatanabe(Hokkaido University)
Cited by 0
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654